MINIMISATION OF RISKS ASSOCIATED WITH THE USE OF POLLEN-BASED MEDICINES, AT THE STAGE OF POLLEN COLLECTION

The aim of the study is the elaboration of Rules for Harvesting/Collecting of Pollen to minimize the risks associated with the use of pollen-based medicinal products.Materials and methods. The following electronic resources were used in the study: PubMed, Medline, ScienceDirect, Web of Science, Scop...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Taube (Author), T. A. Buyanova (Author), E. I. Sakanyan (Author)
Format: Book
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2022-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_5f7c55a888324fceb8d2f92517c11a4d
042 |a dc 
100 1 0 |a A. A. Taube  |e author 
700 1 0 |a T. A. Buyanova  |e author 
700 1 0 |a E. I. Sakanyan  |e author 
245 0 0 |a MINIMISATION OF RISKS ASSOCIATED WITH THE USE OF POLLEN-BASED MEDICINES, AT THE STAGE OF POLLEN COLLECTION 
260 |b Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute,   |c 2022-05-01T00:00:00Z. 
500 |a 2307-9266 
500 |a 2413-2241 
500 |a 10.19163/2307-9266-2022-10-2-154-163 
520 |a The aim of the study is the elaboration of Rules for Harvesting/Collecting of Pollen to minimize the risks associated with the use of pollen-based medicinal products.Materials and methods. The following electronic resources were used in the study: PubMed, Medline, ScienceDirect, Web of Science, Scopus, Google Scholar, eLibrary, World Allergy Organization, Cochrane Database, Stallergenesgreer, Allergenscienceandconsulting, Pharmacopoeia, Fda.gov, fs.usda.gov, Ema.europa.eu. The analysis covered the period from January 1, 2010 until December 31, 2021.Results. Currently, there are some general requirements for the quality of pollen in Russia, but there are no controls or standardised procedures for harvesting, drying, and purification of pollen. The USA and EU also lack established qualification programmes for pollen-collecting companies and/or individual pollen collectors. Regulatory authorities establish requirements only for visual control of raw materials or delegate responsibility to the manufacturer. The analysis of the existing regulatory documentation revealed lack of requirements for collection, storage, and processing of pollen used as the raw material for the production of allergen products. This calls for the elaboration of appropriate regulatory documents. The authors have compiled the Rules for Harvesting/Collection of Pollen, which include 6 parts. The Rules are intended for individuals directly involved in harvesting/collection of pollen, and contain requirements for pollen collectors, the process of pollen collection, documentation, storage, and transportation.Conclusion. The authors have prepared the Rules for Harvesting/Collecting of Pollen, which include 6 parts. The Rules cover the whole process of pollen collection and all related processes. The implementation of this document will improve the process of pollen collection, thus reducing the risks associated with the use of pollen-based medicines. Further studies will assess the impact of the pollen quality on the safety of medicinal products. 
546 |a RU 
690 |a allergen-specific immunotherapy 
690 |a herbal substances 
690 |a safe use of medicinal products 
690 |a good collection practice 
690 |a adverse drug reactions 
690 |a pollen 
690 |a allergen extract 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Фармация и фармакология (Пятигорск), Vol 10, Iss 2, Pp 154-163 (2022) 
787 0 |n https://www.pharmpharm.ru/jour/article/view/1069 
787 0 |n https://doaj.org/toc/2307-9266 
787 0 |n https://doaj.org/toc/2413-2241 
856 4 1 |u https://doaj.org/article/5f7c55a888324fceb8d2f92517c11a4d  |z Connect to this object online.